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In quantitative biochemical studies of aqueous
extracts of psoriatic scales, decreased free amino
nitrogen has been found with increased amounts
of reducing substances, pentose, soluble proteins,
and sulfhydryl groups (1). In addition to
pentose, other components of nucleic acids are
increased, including phosphate and purine and
pyrimidine bases (2). Increased amounts of
hexosarnine and uronic acid have also been
found (2), and in the epidermis there are in-
creased quantities of glycogen (3)
Changes in lipids occur, and in the psoriatic
skin increased phospholipids are found in the
scales with decreased quantities of unsaturated
fatty acids and esterifled cholesterol in the epi-
dermis (4).
The evaluation of cutaneous enzyme activity
in the psoriatic epidermis by quantitative
biochemical studies has revealed increased
activities of the enzymes aldolase and lactic,
glutamic, and malic dehydrogenases (5), and
increased succinic dehydrogenase activity has
been determined histochemically (3). More
recent biochemical studies have demonstrated
decreased glucose-6-phosphate dehydrogenase
in psoriatic scales as compared to normal epi-
dermis (6).
Histochemical studies of glucose-6-phosphate
dehydrogenase have not, to our knowledge,
been reported in the skin of patients with
psoriasis. Further, although a biochemical
enzyme assay of the epidermis provides quanti-
tative information, the values obtained repre-
sent the average enzyme activity of all epi-
dennal cells. The anatomic cellular alterations
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Punch biopsy specimens of the skin were ob-
tained from 10 patients with clinically typical
psoriasis. In each instance, a specimen was ob-
tained from an area of uninvolved skin as well
as from an early lesion. Two of the patients were
subsequently treated with topical steroids and
one with coal tar baths. Repeat biopsy specimens
obtained from these patients included a treated
lesion, an untreated lesion, and uninvolved skin
in each case. As controls, biopsy specimens were
obtained from 10 persons without dermatologic
diseases.
The tissue was immediately frozen on dry ice,
and sections 10c thick were cut in a cryostat
(—18°C) within 30 minutes after freezing. A small
portion of each specimen was fixed in formalin for
the preparation of hematoxylin and eosin-stained
sections.
For the demonstration of enzyme activity, the
frozen sections were incubated immediately after
sectioning at 37°C in substrate solutions consisting
of 5 ml of 0.1 M veronal buffer (0.1 M phosphate
buffer was used to demonstrate succinic dehydro-
genase and DPNH-diaphorase activities), pH 7.4,
containing 2.5 mg of the p-nitrophenyl-substituted
ditetrazolium salt (Nitro-BT). In each instance,
sections of uninvolved skin and sections from nor-
mal control patients were incubated simultaneously
with sections of the psoriatic lesion in each of
the different substrates. The following enzymes
were evaluated by adding the appropriate com-
ponents to the buffer containing Nitro-BT:
Glucose-6-phosphate dehydrogenase
1. Glucose-6-phosphate, disodium salt, 15 mg
2. TriphosphopyTidine nucleotide (TPN), 2.5
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in psoriasis vary considerably in the different
layers of the epidermis. Since anatomic homo-
geneity is lacking, it is important to evaluate
the enzyme activity in each of the layers, and a
determination of the metabolic potential of
individual cell groups rather than the total
activity of all combined layers is essential.
This study was undertaken to evaluate the
relative intensity and localization of enzyme
activity in the skin of patients with psoriasis.
The histochemical methods were directed
toward an assessment of enzymes involved in
Krebs cycle, glycolytic, and pentose phosphate
pathway activity.
mg
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3. KCN, 1.5 rng
Succinic dehydrogenase
1. Sodium succinate, 54 mg
Lactic dehydrogenase
1. Sodium lactate, 24 mg
2. Diphosphopyridine nucleotide (DPN), 2.5
mg
3. KCN, 1.5 mg
TPNH-dinphorase
1. TPNH, 2.5 mg
DPNH-diaphorase
1. DPNH,2.Smg
The final volume in each instance was 5 ml,
and the final pH was 7.4.
To evaluate the specificity of the reactions, sec-
tions from each specimen were incubated in solu-
tions containing all of the components but indi-
vidually excluding the specific substrate.
After incubation, the sections were fixed in
buffered formalin for 15 minutes and then mounted
in glycerogel.
RESULTS
The intensity and distribution of enzyme
activity were the same in the skin of the nor-
mal control patients and in the uninvolved skin
from the patients with psoriasis. Activity of
all of the enzymes was confined to the cyto-
plasm of the cells. The distribution and intensity
of enzyme activity in these specimens were as
follows: Glucose-6-phosphate dehydrogenase
was not demonstrable in the epidermis but was
confined to the pilosebaceous units, with great-
est activity in the sebaceous glands. Lactic
dehydrogenase, DPNH-diaphorase, and TPNH-
diaphorase activities were relatively uniformly
distributed throughout the epidermis with
slight accentuation in the basal layers. Succinic
dehydrogenase was demonstrable in all layers
of the epidermis, with greater accentuation of
activity in the deeper layers than encountered
with the other enzymes evaluated.
In the untreated lesion of psoriasis, strong
glucose-6-phosphate dehydrogenase activity oc-
curs focally in the superficial cells of the
malpighian layer, the stratum granulosum, and
the overlying parakeratotic layer (Figs. 1—4).
Activity of this enzyme is not demonstrable in
other cells of the epidermis with this method.
In the areas of intense glucose-6-phosphate
dehydrogenase activity, TPNH-diaphorase is
also greatly increased (Figs. 5—7). In contrast,
the activities of succinic and lactic dehydrogen-
ase are markedly decreased in these areas, and
reduced activity of these enzymes also occurs
throughout the middle and superficial layers of
the thickened epidermis. A similar but less
striking reduction of DPNH-diaphorase ac-
tivity also occurs. The basal cell layer and the
deep cells immediately above it demonstrate
greater activity of succinic and lactic dehy-
drogenase and DPNH-diaphorase than that
found in the skin from control patients and
uninvolved areas from the psoriatic patients.
The increased activities of these enzymes are
most marked in areas of acanthosis (Figs. 8—13).
In the treated lesions, enzyme activity had
returned to the pattern found in normal skin,
although slight to moderate acanthosis and
parakeratosis persisted (Figs. 14, 15). The
same response was found following both forms
of therapy.
No enzyme activity was demonstrable in
the sections incubated in the control solutions
lacking the specific substrate.
DISCUSSION
Pronounced alterations of enzyme activity
occur in the lesions of psoriasis; enzyme ac-
tivity in the skin from uninvolved areas of the
patient with psoriasis, however, is similar to
that found in the skin of normal individuals.
These changes are characterized by the appear-
ance of intense focal activity of glucose-6-
phosphate dehydrogenase in the superficial
cells of the epidermis, with lesser degrees of
activity in the overlying parakeratotic scales.
This finding is in sharp contrast to that of the
normal epidermis, where activity of this en-
zyme can be demonstrated only in the pilo-
sebaceous units. Increased TPNH-diaphorase
activity occurs in the same foci of increased
glucose-6-phosphate dehydrogenase activity. In
these areas, and extending deeper into the mid-
dle third of the epidermis, there is decreased
to absent activity of succinic and lactic de-
hydrogenase, as well as diminished DPNH-
diaphorase activity. In the basal layer and
lower third of the epidermis, however, the
activity of DPNH-diaphorase and succinic
and lactic dehydrogenase is much greater than
in the normal skin.
These findings suggest decreased glycolytic
and Krebs cycle activity in the upper layers of
the epidermis with the appearance of strong
activity of the pentose phosphate pathway in
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FIG. 1. Glucose-6-phosphate dehydrogenase, normal skin. Enzyme activity is confined to the pilo-
sebaceous units and is represented by the darkly staining areas in the sebaceous glands and inner layers
of the hair follicle. X 23.
FIG. 2. Glucose-6-phosphate dehydrogenase, section of uninvolved area of skin from the same patient
whose psoriatic lesion is illustrated in Figs. 3, 4, 6, and 7. There is no demonstrable enzyme activity
in the epidermis. x 185.
FIG. 3. Glucose-6-phosphate dehydrogenase, psoriasis. Strong enzyme activity is present and is con-
fined to the more superficial epidermal cells and the parakeratotic layer. X 172.
FIG. 4. Glucose-6-phosphate dehydrogenase, psoriasis. In identifiable epidermal cells enzyme activity
is intracytoplasmic. X 185.
these cells. In contrast, in the basal layers con-
taining rapidly proliferating cells, the enzymes
concerned with glycolysis and Krebs cycle
activity exhibit greatly increased activity, and,
as in the normal skin activity of the enzyme,
glucose-6-phosphate dehydrogenase, catalyzing
an early step in the pentose phosphate pathway
cannot be demonstrated in these cells.
Stimulated activity of the pentose phosphate
pathway may be the explanation for the in-
creased amounts of pentose found in psoriatic
scales. Although it has been proposed that the
increased pentose reflects abnormal nuclear
decomposition (2), the finding of increased
glucose-6-phosphate dehydrogenase activity
may equally well indicate that there is an in-
creased synthesis of pentose not necessarily
related to the decomposition of nucleic acids.
The mechanism (s) responsible for the all—
pearance of increased glucose-6-phosphate de-
hydrcgenase activity in the epidermis in areas
other than pilosebaceous units is not known.
Several possibilities exist, however: a. There
may be increased cle novo synthesis of enzyme
protein. b. An activator of the enzyme may be
present. c. An inhibitor of enzyme activity
may have been removed. d. It has been pro-
posed that increased enzyme activity in the
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FIG. 5. TPNH-diaphorase, section from the same block of tissue illustrated in Fig. 2. The distribu-
tion of enzyme activity is relatively uniform in the epidermis, with slight accentuation in the basal
layers. X 71.
FIG. 6. TPNH-diaphorase, same biopsy specimen as illustrated in Figs. 3 and 4. Enzyme activity is
focally increased in the more superficial epidermal cells, and staining is present in the parakeratotic
layer. X 31.
FIG. 7. TPNH-diaphorase, same section as illustrated in Fig. 6. In identifiable epidermal cells enzyme
activity is intracytoplasmic. Compare with Fig. 4. X 186.
FIG. 8. Succinic dehydrogenase, section of uninvolved area of skin from patient whose psoriatic le-
sion is illustrated in Fig. 9. Enzyme activity is greater in the deeper layers of the epidermis than in
the more superficial zones. X 71.
psoriatic scale might be the result of cellular
dehydration with concentration of the enzyme
(6). e. TPNII-diaphorase may be a limiting
factor in the demonstration of glucose-6-phos-
phate dehydrogenase activity, and the observed
increase in the latter may merely reflect an
increase in available TPNII-diaphorase. f. In-
creased amounts of glucose-6-phosphate de-
hydrogenase may be carried to the epidermis
by a greater secretion of lipid from sebaceous
glands. The mechanism(s) cannot be deter-
mined from the experimental data; possibili-
ties d, e, and f seem unlikely, however. It is
difficult to believe that cells lacking demon-
strable glucose-6-phosphate dehydrogenase ac-
tivity that surround anatomically similar cells
having strong activity of this enzyme differ
from the latter cells with regard to their en-
zyme activities by virtue of having different
degrees of dehydration. It seems unlikely that
glucose-6-phosphate dehydrogenase would be
selectively concentrated. If the other enzymes
evaluated are also concentrated, one might ex-
pect to find increased activities of these sys-
tems, but this was not the case.
It is likely that increased activity of TPNII-
diaphorase allows the demonstration of increased
glucose-6-phosph ate dehydrogenase activity.
The presence of demonstrable TPNII-diaphor-
ase in normal epidermis and the absence of
demonstrable glucose-6-phosphate dehydro-
genase activity in these areas, however, sug-
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gest that the former is not the limiting factor
in the demonstration of glucose-6-phosphate
dehydrogenase activity. In short, the appear-
ance of glucose-6-phosphate dehydrogenase ac-
tivity does not seem to be an "unmasking"
of this enzyme brought about solely by in-
creased available TPNH-diaphorase. If glu-
cose-6-phosphate dehydrogenase were mobilized
from the sebaceous glands to the superficial
layers of the epidermis, it is likely that one
would find activity of this enzyme in an inter-
cellular rather than an intracellular distribu-
tion. Further, deficient sebum formation in
psoriasis has been reported (4).
Glucose-6-phosphate dehydrogenase is in-
hibited by sulfhydryl inhibitors (7), and stim-
ulated activity of this enzyme by the increased
sulfhydryl content of the psoriatic skin remains
a distinct possibility. Similarly, the role of
sulfhydryl groups in the increased activity of
this enzyme and the possibility of increased
glucose-6-phosphate dehydrogenase synthesis
will require further biochemical investigation.
The histochemical observation of glucose-6-
phosphate dehydrogenase activity in strong
concentration in sebaceous glands with no
demonstrable activity in the normal epi-
dermis is in keeping with the data obtained
from a quantitative assay of glucose-6-phos-
phate dehydrogenase in normal skin by Her-
shey et ol (8). They reported that 87 per cent
of the glucose-6-phosphate dehydrogenase ac-
tivity found in the skin occurred in pilosebace-
ous units, but only slight activity was observed
in epidermal cells. Assuming that the epidennis
is not contaminated with material from se—
baceous glands, there apparently is a small
amount of glucose-6-phosphate dehydrogenase
activity in the normal epidermis that cannot
be detected by the histochemical methods
used, and their quantitative results correlate
well with our histochemical findings. In a histo-
chemical study of normal skin, Mustakallio (9)
found glucose-6-phosphate dehydrogenase ac-
tivity in the epidermis; the histochemical
method employed, however, was different from
the one in this study. In the investigation by
Mustakallio, sodium fluoride was used to in-
hibit glycolytic enzymes and increase the
amount of demonstrable glucose-6-phosphate
dehydrogenase activity.
The finding of decreased succinic and lactic
dehydrogenase activities in the middle as well
as the more superficial layers of the epidermis
in the psoriatic lesions is somewhat at variance
with other reports illustrating strong enzyme
activities in these areas as well as in the deeper
layers of psoriatic lesions (3, 10). Although
this discrepancy may represent biologic varia-
tion or different stages of healing, a difference
in histochemical technics may be responsible. In
our study, the duration of incubation of the
sections in the substrate was carefully con-
trolled by incubating the control sections of
uninvolved and normal skin in the same solu-
tion as the sections of the lesion. As soon as
formazan deposition in the control section was
complete, the reaction was terminated, and
over-staining was avoided.
The different alterations of enzyme activity
in the various layers of the epidermis have
raised several questions that cannot be answered
at this time. It will be of interest to determine
whether the increased glucose-6-phosphate de-
hydrogenase activity in the epidermis is a
primary event or whether it occurs only after a
FIG. 9. Succinic dehydrogenase, psoriasis. Darkly
staining areas of intense enzyme activity are
confined to the deep epidermal cells, with greatest
activity in the depths of the acanthotic zones.
Little or no activity is present in the cells above
these layers. X 65
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Flu. 10. Lactic dehydrogenase, uninvolved area of skin from patient whose psoriatic lesion is illus-
trated in Fig. 11. There is a relatively uniform distribution of enzyme activity in the epidermis. X 71.
Fia. 11. Lactic dehydrogenase, psoriasis. Enzyme activity is increased in the epidermal cells of the
basal cell layer and those immediately above the latter. X 71.
Fiu. 12. DPNH-diaphorase, uninvolved area of skin from patient whose psoriatic lesion is illustrated
in Fig. 13. A relatively uniform distribution of enzyme activity is present in the epidermis. X 180.
Fiu. 13. DPNH-diaphorase, psoriasis. Enzyme activity is increased in the deeper epidermal cells
and moderately decreased in the more superficial layers. X 78.
Flu. 14. Glucose-6-phosphate dehydrogenase, psoriatic lesion treated with coal tar baths for 6 weeks
prior to biopsy removal. Although acanthosis, papillomatosis, and hyperkeratosis persist, there is
no demonstrable enzyme activity. X 71
Fiu. 15. Lactic dehydrogenase, psoriatic lesion treated with topical steroids for 2 weeks prior to
biopsy removal. A relatively normal distribution and intensity of enzyme activity is present. X 71.
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reduction in the activity of the other enzymes
cited, and also whether any of the changes in
enzyme activity precede or merely accompany
the structural alterations of psoriasis. In the 3
treated patients of this study, healing of the
psoriatic lesion was characterized by a return
to the normal pattern of enzyme activity before
the anatomic changes had completely regressed.
The specificity of the enzymatic alterations
requires further evaluation to determine
whether these changes occur in other lesions
having features similar to psoriasis, such as
hyperkeratosis, parakeratosis, and acanthosis.
The metabolic implications of the altered en-
zyme activities must be evaluated by addi-
tional biochemical studies of different cell
layers in the epidermis.
It is hoped that the data obtained will pro-
vide a basis for further investigations and sug-
gest other approaches to the problem of
metabolic alterations in the skin of patients
with psoriasis.
SUMMARY
Alterations of oxidative enzyme activity
were found in psoriatic lesions from 10 pa-
tients with psoriasis. The changes were char-
acterized by intense glucose-6-phosphate de-
hydrogenase and TPNH-diaphorase activity in
the more superficial layers of the epidermis
and in parakeratotic scales. In these areas there
was decreased activity of succinic dehydrogen-
ase, lactic dehydrogenase, and DPNH-diaphor-
ase. In the deeper layers of the epidermis, in-
creased activity of the latter 3 enzymes was
found, with the greatest increase occurring in
the depths of acanthotic zones.
Healing of the lesions was marked by a re-
turn to the normal pattern of enzyme activity,
although anatomic changes persisted.
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